Azenta, Inc.
Financials
Valuation Metrics
Azenta, Inc.'s Market Cap is $1.47B. At end of 2025 it was $1.53B. Ranked #2235 of 3,121 in US market (top 72%), #890 of 1,463 on NASDAQ (top 61%), #136 of 205 in Health Care Equipment & Services (top 66%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $1.47B | US#2,235/3,121 Sec#136/205 |
| Revenue | $614M | US#2,172/3,121 Sec#135/205 |
| Net Income | $-123M | US—/3,121 Sec—/205 |
| Total Assets | $1.88B | US#2,128/3,121 Sec#109/205 |
| Net Assets | $1.51B | US#1,469/3,121 Sec#75/205 |
| Employees | 3,000 | US#1,476/3,121 Sec#104/205 |
| Value | ||
| P/B | 0.98x | US#357/3,121 Sec#19/205 |
| P/S | 2.40x | US#1,460/3,121 Sec#101/205 |
| FCF Yield | 0.67% | US#2,216/3,121 Sec#136/205 |
| Profitability | ||
| ROE | -8.14% | US#2,335/3,121 Sec#130/205 |
| ROA | -6.55% | US#2,584/3,121 Sec#146/205 |
| Op. Margin | -3.49% | US#2,450/3,121 Sec#142/205 |
| Revenue Growth | 4.85% | US#1,824/3,121 Sec#135/205 |
| Financial Health | ||
| Debt Ratio | 24.24% | US#272/3,121 Sec#26/205 |
| Total Debt | $54M | US#2,600/3,121 Sec#154/205 |
| FCF | $10M | US#2,240/3,121 Sec#138/205 |
| Cash | $190M | US#1,776/3,121 Sec#107/205 |
| Current Ratio | 2.50x | US#976/3,121 Sec#96/205 |
| Dividend | ||
| Div. Yield | 0.00% | US—/3,121 Sec—/205 |
| Div. Growth | -75.01% | US—/3,121 Sec—/205 |
| Payout Ratio | 0.00% | US—/3,121 Sec—/205 |
| Performance | ||
| 1Y Return | 10.41% | US#1,452/3,121 Sec#109/205 |
| 1M Return | 1.97% | US#718/3,121 Sec#79/205 |
| From 52W High | -19.41% | US#1,466/3,121 Sec#103/205 |
| 1Y MDD | -60.94% | US#2,797/3,121 Sec#174/205 |
| Trading | ||
| Volume | 641,098 shares | US#1,782/3,121 Sec#119/205 |
| Trading Value | $22M | US#1,830/3,121 Sec#127/205 |
| Per Share | ||
| EPS | $-2.81 | US—/3,121 Sec—/205 |
| BPS | $34.47 | US#770/3,121 Sec#50/205 |
Company Info
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.